August 2012
-
Following unprecedented growth in 2011 and to facilitate further growth and leadership succession, Team Consulting is looking to recruit a Commercial Director. You will be responsible for leading the continued profitable growth in sales. This… Read more . . .
-
Team Consulting has announced two new hires: Mark Shepherd, formerly Physical Properties Scientist in respiratory product development at GSK, and Human Factors and User Research Consultant Ben Cox. Shepherd, who has experience with dry powder… Read more . . .
-
California-based Impax Pharmaceuticals has acquired exclusive US rights to several dosage forms of Zomig zolmitriptan, including the nasal spray formulation, from AstraZeneca. Zomig nasal spray is approved in the US for the treatment of migraine… Read more . . .
-
SkyePharma CEO Axel Mueller has resigned “to pursue other interests,” according to the company, and will be replaced by current Chief Financial Officer Peter Grant. The company’s announcement says that Grant, who has been CFO… Read more . . .
-
Contract research organization Melbourn Scientific has announced the promotion of Derek Solomon to Operations Director, effective immediately. Solomon, who joined the company in 2005, previously held the title of Laboratory Manager and oversaw Melbourn’s addition… Read more . . .
-
After having its first offer rejected by ISTA Pharmaceuticals, and after ISTA indicated that an increased offer was still insufficient, Valeant Pharmaceuticals has withdrawn its offer of $7.50 per share a day before its announced… Read more . . .
-
A company called Rapid Fire Marketing says that its subsidiary Medical Cannabis Management is launching a tetrahydrocannabinol (THC) e-cigarette in the US immediately and will follow with a second-generation device in 30-60 days. The device,… Read more . . .
-
Spanish pharmaceutical company Almirall and Belgian biotech Galapagos have entered into a three-year agreement “aimed at delivering drug development candidates directed to a key respiratory target of interest to Almirall.” According to the companies, the… Read more . . .
-
Aptar Pharma has opened a new manufacturing facility in Rabale, Navi Mumbai, India, where it will produce the DF30 metering valve for pressurized metered dose inhalers (MDIs) and spray pump assemblies for nasal spray delivery.… Read more . . .
-
Meda Pharmaceuticals has filed a patent infringement suit against Apotex and Perrigo in US District Court in regard to their generic versions of its Astepro azelastine nasal spray for the treatment of rhinitis. The suit… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland